SCHOLAR ROCK HOLDING CORPORATION Financials Scholar Rock Holding Corporation
Equities
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.195 USD | -10.99% |
|
-21.48% | -51.09% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 391.2 | 1,632 | 872.1 | 467.6 | 1,356 | 823.9 | - | - |
| Enterprise Value (EV) 1 | 391.2 | 1,497 | 709.3 | 414 | 1,356 | 567.7 | 459.3 | 454.1 |
| P/E ratio | -7.12 x | -17.3 x | -6.92 x | -4 x | -9.45 x | -3.84 x | -4.41 x | -7.46 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 19.1 x | 106 x | 46.3 x | 14.1 x | - | - | 28.6 x | 5.81 x |
| EV / Revenue | 19.1 x | 97.2 x | 37.7 x | 12.5 x | - | - | 15.9 x | 3.2 x |
| EV / EBITDA | - | -17,529,769 x | -5,571,747 x | - | - | - | - | - |
| EV / FCF | -5.99 x | -23.3 x | -5.37 x | -3.1 x | - | -2.99 x | -2.14 x | -3.83 x |
| FCF Yield | -16.7% | -4.3% | -18.6% | -32.3% | - | -33.4% | -46.7% | -26.1% |
| Price to Book | - | 6.36 x | 5.3 x | 2.07 x | - | 3.86 x | 3.27 x | 3.51 x |
| Nbr of stocks (in thousands) | 29,678 | 33,639 | 35,108 | 51,663 | 72,143 | 79,754 | - | - |
| Reference price 2 | 13.18 | 48.53 | 24.84 | 9.050 | 18.80 | 9.210 | 9.210 | 9.210 |
| Announcement Date | 3/12/20 | 3/9/21 | 3/7/22 | 3/7/23 | 3/19/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 20.49 | 15.4 | 18.82 | 33.19 | - | - | 28.82 | 141.8 |
| EBITDA | - | -85.39 | -127.3 | - | - | - | - | - |
| EBIT 1 | -54.54 | -86.88 | -129.9 | -134.4 | -171.3 | -237.6 | -238.2 | -147 |
| Operating Margin | -266.16% | -564.03% | -690.48% | -404.81% | - | - | -826.54% | -103.73% |
| Earnings before Tax (EBT) 1 | -51 | -86.48 | -131.8 | -134.5 | -165.8 | -234.6 | -229.4 | -142.9 |
| Net income 1 | -51 | -86.48 | -131.8 | -134.5 | -165.8 | -234.6 | -229.4 | -142.3 |
| Net margin | -248.88% | -561.47% | -700.46% | -405.21% | - | - | -796.1% | -100.39% |
| EPS 2 | -1.850 | -2.810 | -3.590 | -2.260 | -1.990 | -2.400 | -2.090 | -1.235 |
| Free Cash Flow 1 | -65.34 | -64.36 | -132 | -133.8 | - | -189.8 | -214.3 | -118.6 |
| FCF margin | -318.87% | -417.83% | -701.73% | -402.97% | - | - | -743.63% | -83.68% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/9/21 | 3/7/22 | 3/7/23 | 3/19/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4.049 | 33.19 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | -38.35 | - | - | - | - | - | - | - | - |
| EBIT 1 | -35.36 | -6.933 | -43.15 | -43.86 | -40.43 | -40.51 | -39.08 | -43.67 | -48.03 | -58.42 | -58.68 | -59.37 | -59.83 | -70.82 | -74.64 |
| Operating Margin | -873.4% | -20.89% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -35.91 | -7.95 | -44 | -43.3 | -39.26 | -39.38 | -37.92 | -42.36 | -46.13 | -56.85 | -58.51 | -59.4 | -59.93 | -66.54 | -70.92 |
| Net income 1 | -35.91 | -7.95 | -44 | -43.3 | -39.26 | -39.38 | -37.92 | -42.36 | -46.13 | -56.85 | -58.51 | -59.4 | -59.93 | -66.54 | -70.92 |
| Net margin | -886.98% | -23.95% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -0.9700 | -0.2100 | -1.060 | -0.5500 | -0.4600 | -0.4900 | -0.4700 | -0.5300 | -0.5000 | -0.5900 | -0.6165 | -0.6217 | -0.5865 | -0.6050 | -0.6200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/7/22 | 5/16/22 | 8/8/22 | 11/14/22 | 3/7/23 | 5/9/23 | 8/9/23 | 11/7/23 | 3/19/24 | 5/7/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 136 | 163 | 53.5 | - | 256 | 365 | 370 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -65.3 | -64.4 | -132 | -134 | - | -190 | -214 | -119 |
| ROE (net income / shareholders' equity) | - | -46.3% | -60.9% | -62.2% | - | -93.5% | -83.8% | -13.1% |
| ROA (Net income/ Total Assets) | - | -29.6% | -38.1% | -40.6% | - | -67.3% | -62.5% | -10.2% |
| Assets 1 | - | 292.3 | 346.4 | 331.3 | - | 348.4 | 367.1 | 1,391 |
| Book Value Per Share 2 | - | 7.640 | 4.690 | 4.370 | - | 2.380 | 2.820 | 2.620 |
| Cash Flow per Share | - | -1.960 | - | - | - | - | - | - |
| Capex 1 | - | 4.09 | 5.25 | 1.06 | - | 8.65 | 12 | 15.7 |
| Capex / Sales | - | 26.54% | 27.89% | 3.21% | - | - | 41.47% | 11.04% |
| Announcement Date | 3/12/20 | 3/9/21 | 3/7/22 | 3/7/23 | 3/19/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9.21
USD
Average target price
26.25
USD
Spread / Average Target
+185.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -51.09% | 824M | |
| +8.38% | 115B | |
| +10.13% | 105B | |
| -11.69% | 22.71B | |
| +2.21% | 21.83B | |
| -10.88% | 18.18B | |
| -41.90% | 16.52B | |
| -16.00% | 16.01B | |
| +2.28% | 14.14B | |
| +20.54% | 10.71B |
- Stock Market
- Equities
- SRRK Stock
- Financials Scholar Rock Holding Corporation
